Renal involvement of mixed connective tissue disease (MCTD) shows systemic lupus erythematosus (SLE)-like immune complex glomerulonephritis. The prognosis of this condition is generally good. We report the case of an elderly female patient with MCTD who developed autoimmune pleurisy and rapidly progressive glomerulonephritis. Myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA) was positive with a titer of 59.0 EU. Anti-DNA antibody and complement levels were normal. Renal biopsy revealed crescentic glomerulonephritis and mild mesangial proliferation. However, immunofluorescence examination revealed immune-complex glomerulonephritis. These findings suggest that the renal involvement of MCTD developed concurrently with MPO-ANCA-related glomerulonephritis.
Introduction
Mixed connective tissue disease (MCTD) was defined in 1972 by Sharp et al as a connective tissue disorder characterized by overlapping features of systemic lupus erythematosus (SLE), progressive systemic sclerosis (PSS), and polymyositis (PM). Serologically, MCTD is distinguished by the presence of high titers of anti U1-ribonucleoprotein (RNP) antibody (1) . Histopathological investigation revealed renal involvement in 15-26% of MCTD patients (1, 2) . Pathological findings indicate some forms of immune-complex glomerulonephritis as SLE-like features or intimal thickening of small arteries as PSS-like features. With regard to glomerular lesions, the most common pattern of renal pathology is membranous nephropathy. Mesangial or membranoproliferative changes are occasionally observed (2, 3) . Immunofluorescence staining typically reveals a granular capillary pattern or mesangial pattern for IgG and C3, and occasionally for IgA. Renal involvement of MCTD is usually mild, and steroid therapy is effective in most cases.
MCTD patients, however, may sometimes develop SLE or other collagen diseases, and such patients may show severe renal involvement (4, 5) . Furthermore, acute loss of renal function caused by myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-related necrotizing glomerulonephritis has been rarely reported in MCTD patients (6) (7) (8) . Therefore, lupus nephritis or MPO-ANCA-related necrotizing glomerulonephritis should be considered to be a possible involvement in MCTD patients with rapidly progressive glomerulonephritis (RPGN). Herein, we describe the case of a female patient of MPO-ANCA-positive MCTD who developed both autoimmune pleurisy and RPGN. Pathological findings suggested crescentic glomerulonephritis with immune complex deposition.
Table 1. Laboratory Findings on Admission
following diagnostic criteria of Japanese MCTD Committee: swollen fingers, a high titer of anti-U1 RNP antibody (> 500×), pleurisy as SLE-like manifestation and interstitial pneumonia as systemic sclerosis-like manifestation. At that time, she was receiving 20 mg/day oral prednisolone treatment.
On admission, her blood pressure was 125/75 mmHg and her body temperature was 37.0 . Physical examination revealed anemic conjunctivae, swollen fingers, and edema in the lower limbs. Fine crackling sounds were audible from the lower lung. Laboratory findings (Table 1) indicated an elevated blood sedimentation rate, anemia, microhematuria, proteinuria, and an elevated serum level of CRP. The serum creatinine level was normal. Urinary sediment showed numerous dysmorphic red blood cells (RBC)/high power field (HPF) and RBC cast 2/low power field (LPF). Electrocardiogram was normal. Chest computed tomography examination showed pleural effusion and pulmonary fibrosis. The examination of pleural fluid revealed an increase in the white blood cell count. Neutrophil was particularly predominant (Table 1 ). Therefore, she was suspected to have bacterial pleurisy and was treated with the broad spectrum antibiotic, meropenem. Her clinical course is shown in Fig. 1 . However, meropenem therapy was not effective. Pleural fluid culture was negative for bacteria and mycobacterium tuberculosis. A second examination showed that lymphocytes were predominantly present in the pleural fluid. Differential diagnosis suggested autoimmune pleurisy and an oral dose of 20 mg of prednisolone was initiated on the 13th day of hospitalization. Subsequently, pleural fluid disappeared and serum CRP level decreased.
She developed renal failure with persistent microscopic hematuria and proteinuria, although pleurisy gradually improved. The laboratory findings on the 30th day of hospitalization were as follows: blood urea nitrogen, 63.5 mg/dL; serum creatinine, 2.49 mg/dL; and urinary protein, 1.7 g/day. The urinary findings before admission were not abnormal. The above-mentioned findings were compatible with those of RPGN. Further, although anti-DNA antibody and complement levels were normal, MPO-ANCA was positive with a titer of 59.0 EU. We suspected that MPO-ANCA-related necrotizing glomerulonephritis caused RPGN, and accordingly increased the dose of prednisolone to 30 mg/day (0.6 mg/ kg) according to the therapeutic guideline for RPGN of the Japanese Society of Nephrology on the 35th day. On the 83 rd day of hospitalization, we performed renal biopsy to elucidate the pathological findings. Light microscopy revealed crescentic glomerulonephritis. Fibrocellular crescents were found in 5 out of 8 glomeruli. The remaining glomeruli showed mild mesangial proliferation (Fig. 2) . The severity of tubular atrophy, interstitial cell infiltration, and fibrosis was mild. No small vessel angiitis was observed in the interstitium. Immunostaining showed IgG and C3 in the mesangial pattern and IgA in the peripheral pattern (Fig. 3) . Electron micrograph showed mild subendothelial deposits and mild intraglomerular basement membrane deposits (Fig. 4) . The renal biopsy specimen was diagnosed as segmental mesagial proliferative glomerulonephritis with fibrocellular crescents. After increasing the prednisolone dose, renal function and abnormal urinary findings gradually improved and the serum level of MPO-ANCA decreased. However, she suddenly developed melena on the 86th day of hospitalization. Colonoscopic examination revealed diverticular bleeding in the descending colon. Subsequently, she complained of abdominal discomfort and developed disturbance of consciousness. Abdominal computed tomography examination showed free air in the abdominal cavity. She was diagnosed with perforation of the digestive tract, for which she underwent resection of the perforated diverticulum in the descending colon. She suffered from septic shock, and was admitted to the intensive care unit after operation. However, she died on the 116th day from sepsis. Pathological findings of the surgical specimen revealed perforation of the diverticulitis. 
Discussion
In this report, we describe a MPO-ANCA-positive MCTD patient who developed both autoimmune pleurisy and RPGN. RPGN is usually classified as immune-complex, pauci-immune, and anti-glomerular basement membrane (GBM) type. On admission, she fulfilled the following SLE diagnostic criteria of American College of Rheumatology: autoimmune pleurisy, immune-complex glomerulonephritis, anti-Sm antibody, and anti-nuclear antibody. The findings of immunofluorescence staining and electron micrograph indicated immune-complex glomerulonephritis. The most likely cause of crescentic glomerulonephritis is diffuse lupus nephritis/Class IV (International Society of Nephrology/Renal Pathology Society). However, there are a few conflicting findings with regard to diffuse lupus nephritis.
In diffuse lupus nephritis, the degree of subendothelial deposit formation is roughly correlated with the degree of endocapillary proliferation. The findings of crescent formation are more commonly encountered in biopsy specimens with extensive endocapillary proliferation. Immunofluorescence studies reveal diffuse mesangial and widespread capillary wall staining in diffuse lupus nephritis (9) . Anti-dsDNA antibodies are thought to cause glomerulonephritis by forming complexes with DNA or by binding to glomerular structures (10, 11) . In many patients with SLE, increased renal disease activity is serologically associated with rising titers of anti-DNA antibodies. Furthermore, immune complexmediated activation of complement is assumed to be a major mechanism of tissue injury. The disease activity of lupus nephritis shows a good correlation with serological immune complex levels or complement consumption (12, 13) .
By contrast, the pathological findings of the present patient showed that, despite crescentic glomerulonephritis, light microscopy and electron microscopy revealed mild mesangial proliferation and mild subendothelial deposits. Immunofluorescence also was weakly positive only for IgG, IgA and C3. Nasr et al emphasized that overlapping of other types of glomerulonephritis should be considered in patients with lupus nephritis manifesting crescent formation without significant subendothelial deposits (14) . Serological findings did not reveal the elevation of anti-DNA antibodies. Neither hypocomplementemia nor the elevation of immune complex levels was observed during the clinical course. The abovementioned pathological and serological findings did not suggest the presence of active diffuse lupus nephritis. Then, crescentic glomerulonephritis is not likely to be caused by lupus nephritis.
In terms of diagnostic criteria, this patient is diagnosed with both MCTD and SLE. There have been reports on the difference of clinical manifestations between patients with MCTD and those with MCTD and SLE. The favorable clinical course in the present case is more closely related to MCTD patients. Hypocomplementemia and anti-DNA antibody seem to be specific to patients with MCTD and SLE (4, 15) . In the MCTD patient with high titers of anti-U 1-RNP antibodies, anti-Sm antibodies are sometimes positive. In the diagnostic criteria of Japanese MCTD Committee revised in 2004, the description of anti-Sm antibody positive case was omitted. Taken together, although this patient fulfilled four diagnostic criteria of SLE, the clinical background might be closer to MCTD than to SLE.
Meanwhile, the serum level of MPO-ANCA in the present patient paralleled the clinical course of RPGN, although the titer was low. MPO-ANCA-related glomerulonephritis can be caused in patients with low titers of MPO-ANCA. There have been reports of MPO-ANCA-related polyangiitis with other types of immune-complex glomerulonephritis. In such cases, renal pathological findings revealed features of both glomerulonephritis (16, 17) . In the present patient, all pathological findings, except for crescent formation, were consistent with those of renal involvement of MCTD. In conclusion, we report overlapping MPO-ANCA-related polyangiitis and renal involvement of MCTD in this patient. In the previous reports of MCTD patients with MPO-ANCA-related necrotizing glomerulonephritis, immunofluorescence analysis revealed pauci-immune necrotizing glomerulonephritis (6) (7) (8) , which implies that patients without the renal involvement of MCTD developed MPO-ANCA-related necrotizing glomerulonephritis. This might be the first report on the simultaneous occurrence of the immunecomplex glomerulonephritis of MCTD and MPO-ANCArelated crescentic glomerulonephritis.
Autoimmune pleurisy is an intriguing comorbidity considering the pathogenesis of glomerulonephritis. In the overall clinical course, pleural effusion and abnormal urinary findings were identified at the same time. Thus, renal involvement developed concurrently with the onset of pleurisy, which implies that the same pathogenesis might cause both the lesions. Although the most commonly reported pattern of pulmonary lesions is alveolar hemorrhage and interstitial pneumonia in polyangiitis, pleurisy has been also reported. One study reported that 15% of the patients with microscopic polyarteritis developed pleurisy (18) . MPO-ANCA can be related to the onset of serositis in SLE patients (19) . Katae et al reported MPO-ANCA-related polyangiitis in patients with RPGN and pleurisy without alveolar hemorrhage or interstitial pneumonia (20) . Tomori et al reported a case of SLE in which MPO-ANCA was likely related with pleuritis and pericarditis (21) . In MPO-ANCA-related polyangiitis, pathological changes in the lungs usually develop in accordance with the rapid deterioration of renal function. Hence, in the present patient, MPO-ANCA-related polyangiitis might cause both pleurisy and crescentic glomerulonephritis.
In conclusion, we encountered a rare case of MCTD with autoimmune pleurisy and crescentic glomerulonephritis accompanied by elevated serum levels of MPO-ANCA. The findings of the present study suggest that MPO-ANCArelated glomerulonephritis developed concurrently with renal involvement of MCTD. In addition, MPO-ANCA-related polyangiitis should be considered as a possible complication when MCTD patients show both pleurisy and RPGN.
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